CLC Number:
| [1] Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm[J]. Am J Surg Pathol, 1983, 7(5): 463-475. [2] Haldar K, Martinek IE, Kehoe S. Aggressive angiomyxoma: a case series and literature review[J]. Eur J Surg Oncol, 2010, 36(4): 335-339. [3] Xie Y, Qian Y, Zou B. A giant aggressive angiomyxoma of vulva in a young woman: a case report[J]. Medicine(Baltimore), 2019, 98(2): e13860. doi: 10.1097/MD.0000000000013860. [4] Kawamura M, Matsumoto F, Matsui F, et al. Aggressive angiomyxoma of the vulva mimicking clitoromegaly in a young child[J]. Urology, 2017, 101: 142-144. doi: 10.1016/j.urology.2016.10.034. [5] Chan YM, Hon E, Ngai SW, et al. Aggressive angiomyxoma in females: is radical resection the only option?[J]. Acta Obstet Gynecol Scand, 2000, 79(3): 216-220. [6] Miguez GJ, Dominguez OR, Lozano AP, et al. Aggressive angiomyxoma: imaging findings in 3 cases with clinicopathological correlation and review of the literature[J]. J Comput Assist Tomogr, 2015, 39(6): 914-921. [7] Giraudmaillet T, Mokrane FZ, Delchier-Bellec MC, et al. Aggressive angiomyxoma of the pelvis with inferior vena cava involvement: MR imaging features[J]. Diagn Interv Imaging, 2015, 96(1): 111-114. [8] Sun Y, Zhu L, Chang X, et al. Clinicopathological features and treatment analysis of rare aggressive angiomyxoma of the female pelvis and perineum-a retrospective study[J]. Pathol Oncol Res, 2017, 23(1): 131-137. [9] 钞晓培, 万希润, 滕莉荣. 外阴侵袭性血管粘液瘤累及盆腔伴子宫肌瘤1例及文献复习[J]. 生殖医学杂志, 2018, 27(5): 474-478. [10] Song M, Glasgow M, Murugan P, et al. Aggressive angiomyxoma of the vulva and bladder[J]. Obstet Gynecol, 2017, 130(4): 885-888. [11] Xu H, Sun P, Xu R, et al. Aggressive angiomyxoma in pregnancy: a case report and literature review[J]. J Int Med Res, 2020, 48(7): 300060520936414. doi: 10.1177/0300060520936414. [12] Htwe M, Deppisch LM, Saint-Julien JS. Hormone-dependent, aggressive angiomyxoma of the vulva[J]. Obstet Gynecol, 1995, 86(4 Pt 2): 697-699. [13] Wolf CA, Kurzeja R, Fietze E, et al. Aggressive angiomyxoma of the female perineum in pregnancy[J]. Acta Obstet Gynecol Scand, 2003, 82(5): 484-485. [14] Aguilar-Frasco J, Ruben-Castillo C, Rodríguez-Quintero JH, et al. Aggressive angiomyxoma: giant recurrence successfully treated with wide excision and adjuvant therapy with GnRH analogue[J]. BMJ Case Rep, 2018, 11(1): e226973. doi: 10.1136/bcr-2018-226973. [15] McCluggage WG, Jamieson T, Dobbs SP, et al. Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy[J]. Gynecol Oncol, 2006, 100(3): 623-625. [16] Pannier D, Cordoba A, Ryckewaert T, et al. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis[J]. Crit Rev Oncol Hematol, 2019, 143: 62-66. doi: 10.1016/j.critrevonc.2019.08.007. [17] Zhang P, Song K, Li L, et al. Aggressive angiomyxoma with massive ascites[J]. Gynecol Oncol Case Rep, 2011, 1(1): 12-13. |
| [1] | WANG Moulong, CHEN Yongkun, XING Deguang, QU Liangsuo, WANG Chengwei. A clinical analysis of transcranial Doppler in predicting delayed cerebral ischemia after ruptured aneurysm surgery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 38-41. |
| [2] | LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38. |
| [3] | ZHAO Lu, JIAO Jun, ZHANG Teng, JIAO Xinlin, CUI Baoxia. Expression of LXRα in ovarian carcinoma and effects of T0901317 on SKOV3 cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 49-53. |
| [4] | XIAO Junchao, JIANG Wen, NAN Hui, WANG Peirong. A recombinant adenovirus fiber knob protein sensitizes ovarian cancer cells to cetuximab therapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 1-5. |
| [5] | WANG Ping, CHEN Jing, SHI Qing, FU Yibing. RbAp48 expression and its clinical significance in endometrial adenocarcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 84-87. |
| [6] | LI Zhishuang, YU Qiong, ZHANG Chunhua. Effects of rosiglitazone and GW9662 on the expression of PPAR-γ in JEG-3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 72-76. |
| [7] | ZHAO Yunxia, SONG Jing, ZHANG Cancan, LIN Xueyan, WEI Wei, TIAN Yongjie. CXXC4 promotes sensitivity to chemotherapy drugs in epithelial ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 24-29. |
| [8] | PENG Hui, HE Junmei, SU Xuelian. Expression of serum miR-375 and its clinical significance in the diagnosis and postoperative monitoring of cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 68-71. |
| [9] | XU Zhihong, WU Xiaohua, YAO Tiezhu, WANG Xiaoxiang, DUAN Xiaoyang, SHI Jian. Relationship between mir-99a expression and prognosis of epithelial ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 77-80. |
| [10] | ZHANG Chunxia, ZOU Cunhua, SONG Dongdong, YU Jiang. Effects of P38 mitogen-activated protein kinase signal pathway on the expression of urokinase-type plasminogen activator in ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 68-74. |
| [11] | LI Chen, CHENG Yufeng, LI Ailu. Clinical analysis and type distribution of human papilloma virus among gynecologic outpatients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(11): 73-76. |
| [12] | LÜ Shuqing, WEI Wei, ZHANG Cancan, TIAN Yongjie. Mechanism of HGF/PARP-1 signaling pathway regulating invasion and metastasis of ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 1-7. |
| [13] | TIAN Xinli, JIAO Jun, ZHANG Teng, MA Daoxin, CUI Baoxia. Expression and significance of Th22 and Th17 cells in the peripheral blood of cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 43-47. |
| [14] | LIU Yafei, ZHANG Qishu, YUAN Shoudao, Jason J. Chen. Mass spectrometry analysis of differentially expressed proteins between HPV immortalized cell line and SiHa cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 22-26. |
| [15] | DU Yijiang, XIAO Changyi, YE Hong, TANG Guicheng, LI Jiahua. Expression of human papillomavirus late capsid protein 1 in CaSki cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 17-21. |
|
||
